Several government hospitals throughout Karnataka, India, have been reporting a shortage of anti-rabies vaccine (ARV), compelling the state government to resort to Big Pharma and private players in the open market.
More than 1,000 people have sought the rabies vaccine in Delhi’s Ram Manohar Lohia Hospital, as compared to 200 last year, given the acute lack of supply of the vaccine to state-run hospitals.
Every year, nearly 21,000 people die from the disease in India. Both the vaccine and the rabies immunoglobulin that form the standard treatment are available free of charge at government-run hospitals. But supplies have run out, leaving the government to resort to private players and multinationals.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze